PFAS exposure in early life: Health risks and maternal-fetal transport mechanisms

FHS
June 24, 2024
11:50 am

Polyfluoroalkyl substances (PFAS) are a class of chemicals extensively used in consumer goods production due to their hydrophobic and oleophobic properties and stability.

Merck winds down TIGIT, LAG-3 programs meant to temper Keytruda erosion

After multiple clinical failures, it’s finally the end of the road for Merck’s TIGIT program. The company is dropping development of its anti-TIGIT candidate vibostolimab

December 18, 2024

Amgen reports more Uplizna data in myasthenia gravis ahead of FDA filing

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

March 14, 2025

Researchers discover a molecular switch that regulates lipid metabolism in cells

Our body’s fat metabolism plays a vital role in energy production in our body. A research team at the University of Basel, Switzerland, has discovered

July 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.